Your browser doesn't support javascript.
loading
Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the Difficult.
Falade-Nwulia, Oluwaseun; Sulkowski, Mark S.
Afiliación
  • Falade-Nwulia O; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sulkowski MS; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
J Infect Dis ; 222(Suppl 9): S745-S757, 2020 11 27.
Article en En | MEDLINE | ID: mdl-33245350
The availability of safe, efficacious, oral direct-acting antivirals (DAAs) have ushered in a new era of hepatitis C treatment with potential to eliminate hepatitis C as a public health threat. To achieve population-level effectiveness of these oral DAAs, hepatitis C treatment by a wide range of providers in different settings will be essential to increase the number of persons treated. We provide a clinical review of hepatitis C treatment with a focus on practical tools for management of hepatitis C in majority of currently infected individuals who can be easily cured and optimization of treatment for those in whom treatment may not be as simple.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos